Patrick Kesteven

4.7k total citations · 3 hit papers
51 papers, 3.4k citations indexed

About

Patrick Kesteven is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Patrick Kesteven has authored 51 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 15 papers in Internal Medicine and 12 papers in Surgery. Recurrent topics in Patrick Kesteven's work include Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Patrick Kesteven is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Patrick Kesteven collaborates with scholars based in United Kingdom, Australia and United States. Patrick Kesteven's co-authors include Ann K. Daly, Christopher P. Day, Guruprasad P. Aithal, Farhad Kamali, Peter Avery, Hilary Wynne, Tayyaba Khan, Peter Wood, Barry P. King and Elizabeth Sconce and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Patrick Kesteven

49 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1999 948 citations Guruprasad P. Aithal, Christopher P. Day et al. The Lancet profile →
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

2005 686 citations Tayyaba Khan, Hilary Wynne et al. profile →
A Randomized Trial of Genotype-Guided Dosing of Warfarin

2013 590 citations Patrick Kesteven, Ann K. Daly et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Kesteven United Kingdom	19	1.9k	944	772	565	440	51	3.4k
Niclas Eriksson Sweden	23	2.1k 1.1×	1.2k 1.3×	856 1.1×	439 0.8×	397 0.9×	67	4.2k
Hilary Wynne United Kingdom	28	1.5k 0.8×	690 0.7×	551 0.7×	202 0.4×	310 0.7×	76	3.5k
Charles S. Eby United States	22	903 0.5×	754 0.8×	418 0.5×	628 1.1×	223 0.5×	61	3.0k
Paul E. Milligan United States	18	1.3k 0.7×	1.2k 1.3×	527 0.7×	672 1.2×	252 0.6×	31	2.6k
Charles Eby United States	19	1.5k 0.8×	478 0.5×	609 0.8×	191 0.3×	323 0.7×	36	2.4k
Larisa H. Cavallari United States	40	3.1k 1.6×	1.3k 1.4×	861 1.1×	288 0.5×	289 0.7×	198	5.3k
Deepak Voora United States	27	1.5k 0.8×	802 0.8×	609 0.8×	156 0.3×	211 0.5×	102	3.6k
Edith A. Nutescu United States	34	1.1k 0.6×	2.0k 2.2×	364 0.5×	1.6k 2.8×	171 0.4×	186	4.2k
Andrea Jorgensen United Kingdom	32	1.4k 0.7×	509 0.5×	405 0.5×	113 0.2×	162 0.4×	107	3.7k
Mia Wadelius Sweden	38	4.4k 2.3×	1.4k 1.4×	1.5k 1.9×	285 0.5×	681 1.5×	101	7.2k

Countries citing papers authored by Patrick Kesteven

Since Specialization

Citations

This map shows the geographic impact of Patrick Kesteven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Kesteven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Kesteven more than expected).

Fields of papers citing papers by Patrick Kesteven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Kesteven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Kesteven. The network helps show where Patrick Kesteven may publish in the future.

Co-authorship network of co-authors of Patrick Kesteven

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Kesteven. A scholar is included among the top collaborators of Patrick Kesteven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Kesteven. Patrick Kesteven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wynne, Hilary, et al.. (2016). Impact of age on long‐term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management. British Journal of Clinical Pharmacology. 82(4). 1076–1083. 9 indexed citations

Kamali, Farhad, et al.. (2014). Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England. Age and Ageing. 43(5). 708–711. 7 indexed citations

Wimperis, J. Z., et al.. (2007). Early discharge of patients with pulmonary embolism: a two-phase observational study. European Respiratory Journal. 30(4). 708–714. 65 indexed citations

Lingard, Elizabeth A., et al.. (2007). Venous Thromboembolism in Patients with Primary Bone or Soft-Tissue Sarcomas. Journal of Bone and Joint Surgery. 89(11). 2433–2439. 47 indexed citations

Angus, Brian, et al.. (2006). Localized reactive angioendotheliomatosis. Clinical and Experimental Dermatology. 0(0). 2943710244–???. 10 indexed citations

Kesteven, Patrick, et al.. (2006). Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery. Current Drug Safety. 1(3). 281–287. 4 indexed citations

Khan, Tayyaba, Hilary Wynne, Peter Wood, et al.. (2004). Dietary vitamin K influences intra‐individual variability in anticoagulant response to warfarin. British Journal of Haematology. 124(3). 348–354. 80 indexed citations

Rao, Jagan, Asif Hasan, J.R.L. Hamilton, et al.. (2004). ABO-INCOMPATIBLE HEART TRANSPLANTATION IN INFANTS: THE FREEMAN HOSPITAL EXPERIENCE. Transplantation. 77(9). 1389–1394. 22 indexed citations

Fitzmaurice, David & Patrick Kesteven. (2003). How to evaluate the performance of oral anticoagulation clinics. University of Birmingham Research Portal (University of Birmingham).

10.

Rutter, Martin K., et al.. (2002). QT prolongation in patients with Type 2 diabetes and microalbuminuria. Clinical Autonomic Research. 12(5). 366–372. 14 indexed citations

11.

Dark, John H., Patrick Kesteven, Christopher Snowden, et al.. (2001). Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 122(6). 1162–1166. 14 indexed citations

12.

Kamali, Farhad, et al.. (2001). Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans. American Journal of Hematology. 68(3). 159–163. 13 indexed citations

13.

Kesteven, Patrick, et al.. (2001). Model for assessment of endothelial cell function and viability using the MTT dye test and [<sp>3</sup>H]. Central African Journal of Medicine. 47(7). 177–81.

14.

Kesteven, Patrick. (2000). Traveller's thrombosis. Thorax. 55(90001). 32S–36. 38 indexed citations

15.

Aithal, Guruprasad P., Christopher P. Day, Patrick Kesteven, & Ann K. Daly. (1999). Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. The Lancet. 353(9154). 717–719. 948 indexed citations breakdown →

16.

Barriocanal, L. A., Vivek Mishra, M Tarbit, et al.. (1995). The effect of triglyceride infusion on the regulators of fibrinolysis. Fibrinolysis and Proteolysis. 9(4). 243–246. 1 indexed citations

17.

Kesteven, Patrick, et al.. (1995). Do patients with epistaxis have drug-induced platelet dysfunction?. Clinical Otolaryngology. 20(5). 407–410. 12 indexed citations

18.

Neil, H. A. W., et al.. (1993). Serum insulin, haemostatic function and cardiovascular risk factors in normoglycaemic men and women. Nutrition Metabolism and Cardiovascular Diseases. 3(4). 165–172. 2 indexed citations

19.

Kesteven, Patrick, et al.. (1993). Pleural lymphoma in a patient presenting with malabsorption: an illustration of the clinicopathological behaviour in a case of enteropathy associated T cell lymphoma.. Gut. 34(10). 1463–1466. 6 indexed citations

20.

Beckingham, Ian J., et al.. (1989). Acute thrombocytopenia after De-Nol.. Gut. 30(7). 1016–1017. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact